Roche Holding AG (SWX:ROP)
397.30
-1.90 (-0.48%)
Nov 20, 2026, 2:54 PM CET
Roche Holding AG Employees
Roche Holding AG had 103,249 employees as of December 31, 2024. The number of employees decreased by 356 or 0.34% compared to the previous year. That makes Roche Holding AG the 274th largest employer in the world and 3rd in Switzerland.
Employees
103,249
Change (1Y)
-356
Growth (1Y)
-0.34%
Revenue / Employee
609.78K CHF
Profits / Employee
119.53K CHF
Market Cap
317.17B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 103,249 | -356 | -0.34% |
| Dec 31, 2023 | 103,605 | -8 | -0.01% |
| Dec 31, 2022 | 103,613 | 2,693 | 2.67% |
| Dec 31, 2021 | 100,920 | -545 | -0.54% |
| Dec 31, 2020 | 101,465 | 3,730 | 3.82% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Novartis AG | 75,267 |
| Alcon | 25,000 |
| Lonza Group AG | 20,141 |
| Sandoz Group AG | 20,000 |
| Sonova Holding AG | 18,837 |
| Straumann Holding AG | 11,582 |
| Galderma Group AG | 7,676 |
| Galenica AG | 6,623 |
Roche Holding AG News
- 3 days ago - Roche Secures First U.S. Approval for New Breast-Cancer Pill - WSJ
- 3 days ago - Genentech announces FDA approval of Wilserdly in combination with everolimus - TheFly
- 3 days ago - FDA Approves Genentech's WILSERDLY (Giredestrant), a Next-Generation Oral SERD, for ER-Positive, ESR1-Mutated Advanced Breast Cancer - Business Wire
- 3 days ago - FDA approves Roche's Wilserdly (giredestrant), a next-generation oral SERD, for ER-positive, ESR1-mutated advanced breast cancer - GlobeNewsWire
- 3 days ago - US FDA approves Roche's oral treatment for advanced breast cancer - Reuters
- 4 days ago - Roche receives FDA De Novo authorization for cobas pro i 601 platform - TheFly
- 4 days ago - Roche receives FDA De Novo authorization for cobas® pro i 601 platform with Ionify® Gabapentin assay, advancing automated mass spectrometry for routine clinical laboratories - PRNewsWire
- 4 days ago - Genentech announces FDA approval of Gazyva for primary membranous nephropathy - TheFly